Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression. (1st January 2017)
- Record Type:
- Journal Article
- Title:
- Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression. (1st January 2017)
- Main Title:
- Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression
- Authors:
- Fogaça, Manoela Viar
Cândido-Bacani, Priscila de Matos
Benicio, Lucas Milanez
Zapata, Lara Martinelli
Cardoso, Priscilla de Freitas
de Oliveira, Marcelo Tempesta
Calvo, Tamara Regina
Varanda, Eliana Aparecida
Vilegas, Wagner
de Syllos Cólus, Ilce Mara - Abstract:
- Abstract: Context: Indigofera suffruticosa Miller (Fabaceae) and I. truxillensis Kunth produce compounds, such as isatin (ISA) and indirubin (IRN), which possess antitumour properties. Their effects in mammalian cells are still not very well understood. Objective: We evaluated the activities of ISA and/or IRN on cell viability and apoptosis in vitro, their genotoxic potentials in vitro and in vivo, and the IRN- and ISA-induced expression of ERCC1 or BAX genes. Materials and methods: HeLa and/or CHO-K1 cell lines were tested (3 or 24 h) in the MTT, Trypan blue exclusion, acridine orange/ethidium bromide, cytokinesis-blocked micronucleus (CBMN) and comet (36, 24 and 72 h) tests after treatment with IRN (0.1 to 200 μM) or ISA (0.5 to 50 μM). Gene expression was measured by RT-qPCR in HeLa cells. Swiss albino mice received IRN (3, 4 or 24 h) by gavage (50, 100 and 150 mg/kg determined from the LD50 – 1 g/kg b.w.) and submitted to comet assay in vivo . Results: IRN reduced the viability of CHO-K1 (24 h; 5 to 200 μM) and HeLa cells (10 to 200 μM), and was antiproliferative in the CBMN test (CHO-K1: 0.5 to 10 μM; HeLa: 5 and 10 μM). The drug did not induce apoptosis, micronucleus neither altered gene expression. IRN and ISA were genotoxic for HeLa cells (3 and 24 h) at all doses tested. IRN (100 and 150 mg/kg) also induced genotoxicity in vivo (4 h). Conclusion: IRN and ISA have properties that make them candidates as chemotherapeutics for further pharmacological investigations.
- Is Part Of:
- Pharmaceutical biology. Volume 55:Number 1(2017)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 55:Number 1(2017)
- Issue Display:
- Volume 55, Issue 1 (2017)
- Year:
- 2017
- Volume:
- 55
- Issue:
- 1
- Issue Sort Value:
- 2017-0055-0001-0000
- Page Start:
- 2005
- Page End:
- 2014
- Publication Date:
- 2017-01-01
- Subjects:
- Indigofera suffruticosa -- Indigofera truxillensis -- HeLa cells -- CHO-K1 cells -- cytokinesis-blocked micronucleus assay -- comet assay -- apoptosis
Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13880209.2017.1354387 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18569.xml